Financial Results Novartis Automates New Radioligand Therapy Production Plant Novartis’ Lutathera reduces disease

grandiflora against Candida auris FKBP12 Development and therapeutic perspectives of CXCR4 antagonists for disease

and Immunology Expanding role of CXCR2 and therapeutic potential of CXCR2 antagonists in inflammatory diseases

optogenetically functionalized Drosophila dopamine receptors Targeting CB2R in astrocytes for Parkinson's disease

GPCR-related genes analysis Reviews, GPCRs, and more GPR56, an Adhesion GPCR with Multiple Roles in Human Diseases

Ghrelin receptor signaling in health and disease: a biased view.

of the Clinical Candidate IDOR-1117-2520: A Potent and Selective Antagonist of CCR6 for Autoimmune Diseases

The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards

the promise of unveiling novel insights into cellular signaling and its implications for health and disease

will pave the way for significant advancements in the development of therapeutics for a wide range of diseases

Principles of Pharmacology II Dates: October 31, November 7, 14, 21, December 5 (five sessions) (we skipped Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers Cumulus raising $50M, spinning

Schiff base, and prevents protein degradation, potentially offering therapeutic benefits for retinal diseases6